The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,740.00
Bid: 1,745.00
Ask: 1,746.00
Change: -34.50 (-1.94%)
Spread: 1.00 (0.057%)
Open: 1,776.50
High: 1,776.50
Low: 1,740.00
Prev. Close: 1,740.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Next champions

Wed, 30th Sep 2020 15:02

* European shares back in the black

* Wall Street opens higher

* Chaos marks first Trump-Biden debate

* China's factory activity accelerates
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) and Danilo Masoni (danilo.masoni@thomsonreuters.com) in
Milan.

NEXT CHAMPIONS (1330 GMT)

ESG is not new but it is gaining steam and it will likely be a multi-year trend as asset
managers "are more and more understanding of the power of ESG," Kasper Elmgreen, who heads the
equity platform at Amundi, told us.

He reckons it will be "perhaps the single most interesting development over the next few
years".

But the problem is that everyone is investing in the same companies that are best in class
when it comes to ESG, Elmgreen says.

"If everyone fish in the same corner of the lake, you don't catch so many fish".

If you can spot "tomorrow's best in class", you get the real returns, he added.

Elmgreen says what can help you pick the right investments, is your ability to assess what
is important in different sectors, conduct some qualitative analysis and make sense of data such
as employee engagement and satisfaction, gender diversity, CO2 emission, water usage, recycling
propensity, etc.

"So can we identify the companies that are not yet great but have the potential to become
great in ESG? Because we know for a fact that the companies that have high ESG score, they have
high valuations."

He gives a few examples of what to look at:

- In a bank, look at compliance, security, cyber security data

- In heavy industry: CO2 emission and environmental footprint

- In clothing retailers: consider social effect, such as the supply chain employed, how
these manufacturers treat their employees, what's the environmental impact

"Over the past few months, we've been fortunate enough to witness how bad things can go when
ESG doesn't go well," Elmgreen says.

Examples of scandals this year involved retailer Boohoo and German payments firm Wirecard.

It doesn't have only a "cost for the environment or a cost for the social factor but it has
a significant shareholder cost as well."

(Joice Alves)

*****

COVID MEASURES ARE SLOWING DOWN NPL RECOVERIES (1308 GMT)

Non performing loans are a major concern for the euro zone's economy and for banks, as it
seems we should wait for stimulus plans to no longer be in place to know what the corporate debt
situation across Europe really looks like.

The state of affairs is not reassuring either as NPLs' collections are lower than
anticipated while recoveries have been slowing down.

"Thirteen of the 22 Italian, Portuguese and Spanish transactions covered by our first-half
report show cumulative gross collections (aggregate of all proceeds received in a period for all
positions before any recovery expenses or servicing fees) below those anticipated by servicers
in the original business plans," Moody's says in its semiannual update on Europe's NPL
securitization market.

For transactions behind original projections, average underperformance rose to 25% in the
first half of this year from 13% in the second half of 2019, it adds.

In addition to that measures to contain the virus have affected the judicial systems,
“creating a backlog that will delay NPLs securitisations' gross recoveries.”

Court appraisals, property inspections and auctions were frozen and will be delayed until
courts return to normal activity.

Economic contraction and a material slowdown in business activity across different
jurisdictions is likely to result in a deterioration in banks' asset quality. Stimulus measures
will “delay the crystallisation of many defaults until 2021.”

(Stefano Rebaudo)

*****

RISING DEPOSITS: ONE MORE RISK FOR EZ BANKS (1105 GMT)

Although some investors may be tempted to buy ultra cheap European banks, or at least try to
jump on their occasional stock price rebound, there's another risk looming large: growing
deposits by savers.

Economist Patrik Artus at Natixis has spotted the possible trap and highlights how euro zone
savers have recently been dumping money into bank deposits since they see stocks as being highly
risky and given long-term interest rates are too low.

"If savings concentrate in bank deposits, the banking sector will therefore play a larger
role in the economy but will become riskier," he warns.

Here's his argument in more detail:

* The financing of the economy is increasingly bank-based and decreasingly market-based,
leading
in particular to greater borrower default risk incurred by banks

* Banks' need for capital will increase sharply as their risk-taking will increase and their
balance sheets will expand again

(Danilo Masoni)

*****

U.S. ELECTION RISKS IN FOCUS (1048 GMT)

Markets turned their attention towards U.S. politics on Wednesday after the first U.S.
presidential debate overnight saw President Trump laying the groundwork to dispute the election
while in Deutsche Bank Jim Reid's words: "there was very little substance in the debate and
almost no new information proffered" from both candidates.

"Those looking for any real clarity from last night's presidential debate have been left
empty handed. The debate essentially showed two septuagenarians squabbling amongst themselves
and failing to really commit to anything substantial," says John Woolfitt, director of trading
at Atlantic Markets.

Biden's chances however were rising on betting markets after the debate, with Betfair
Exchange showing the Democratic candidate's probability of winning at 60%, up from 56% before
the debate. Trump has a 40% chance.

Sonja Laud, CIO at LGIM speaking at the firm's media webinar, says her team is closely
watching "the risk of higher taxes that actually all democrats candidates have one way or the
other in their plans."

"It's very clear that market hasn't really paid a lot of attention to political events for
quite some time, and obviously are now trying to catch up".

More readings:

GLOBAL MARKETS-Stocks pull back as acrimonious U.S. debate stokes caution

Insults and interruptions mar first Trump-Biden debate

European stocks sapped by virus, U.S. election worries

(Joice Alves)

*****

SEPTEMBER FLOWS: TINA "STILL IN PLAY" (1004 GMT)

Markets have become more erratic as of late but Barclays finds that the so-called TINA
(there is no alternative) effect that's been supporting equities is "still in play".

It finds that not much de-risking has taken place in September with mutual funds reducing
cash exposure to buy more equities, albeit more selectively.

Global equity funds had 15 billion inflows mtd, while money market funds in contrast saw 133
billion in outflows and have now unwound 30% of their ytd inflows, it notes.

(Danilo Masoni)

*****

A REAL ESTATE BUBBLE IN THE EURO ZONE? (0926 GMT)

Real estate did not suffer much from the coronavirus crisis as lower-for-longer rates and
stimulus plans supported demand, but some cities might have stepped into bubble-risk territory.

According to UBS, the major cities at risk of a bubble are in the euro zone.

Three reasons are behind the recent surge in prices, according to UBS.

Home prices are a backward-looking indicator of the economy as they react with a delay to
economic downturns. Then the number of transactions declined, while most potential home buyers
did not suffer direct income losses in first half of 2020.

"Credit facilities for companies and short-time work schemes mitigated the fallout from the
crisis, supporting employees’ housing affordability," it says.

“It’s clear that the current acceleration is not sustainable. Rents have been falling
already in most cities, indicating that a correction phase will likely emerge when subsidies
fade out and pressure on household incomes increases,” it adds.

In many cities buying from investors willing to rent is going to be subdued as
“price-to-rent ratios have reached a record-high and rental growth is uncertain.”

(Stefano Rebaudo)

*****

OPENING SNAPSHOT: M&A DRIVES TOP MOVERS, SHELL UP, AIRBUS DOWN (0729 GMT)

European shares opened almost flat after earlier indications from futures for a loss.

M&A newsflow is the driver behind top movers.

TP ICAP is down 8% after the world's biggest inter-dealer broker said it's in
advanced talks to buy electronic trading network Liquidnet Holdings for $600-700 million, while
Covestro is down 4.9% on news it will purchase Dutch peer DSM's Resins and
Functional Materials business for about 1.6 billion euros.

In the opposite direction, French utility Suez is up 6.6% after peer Veolia
sweetens its offer for a 29.9% stake in the rival.

Royal Dutch Shell is off to a volatile start. After hitting March lows the stock is
now up more than 1% as it looks investors are giving thumbs up to its plans to cut its workforce
by up to 9,000 10% as part of a major shift to low-carbon energy.

Airbus is down 1.4% after Reuters reports the WTO has authorized the EU to impose
tariffs on U.S. goods worth $4 billion, raising the prospect of more trade frictions ahead

(Danilo Masoni)

*****

SHELL OVERHAUL, MORE M&A, AND CHIPMAKERS ON OUR RADAR (0652 GMT)

The chaotic Trump-Biden debate did nothing to soothe worries over a contested election
outcome and it barely moved the needle in betting markets, which give a narrow Biden victory.

It may be little surprise then that U.S. futures are currently taking a hit, down more than
1%, and the open in Europe isn't going to be much different.

The positive China data may have a negligible impact on sentiment, while a Reuters report
that the WTO has authorized the EU to impose tariffs on U.S. goods worth $4 billion has raised
the prospect of more trade frictions ahead.

In corporate news, Royal Dutch Shell announced on Wednesday plans to cut up to
9,000 jobs, or over 10% of its workforce, as part of a major overhaul to shift the oil and gas
giant to low-carbon energy. Its shares are seen up 1%.

M&A continues with German plastics maker Covestro buying Dutch peer DSM's
Resins and Functional Materials business for about 1.6 billion euros. The news is set
to weigh on Covestro shares, which fell 2.9% in early trade.

In the UK, William Hill has agreed to be acquired by Caesars Entertainment.

In earnings, a downbeat sales forecast from chipmaker Micron could have a negative
readacross for sector peers here in Europe. Infineon shares fell more than 1% in
premarket trade.

In more positive news, Swiss adhesives and construction materials maker Sika looked
upbeat. It confirmed its target for annual sales growth of 6-8% until 2023 and said it expects
more favourable second-half market conditions even as the COVID-19 pandemic continues.

British online fashion retailer Boohoo reported a 51% increase in first half profit
and raised its full year guidance, while shares in IT solutions supplier S&T rose
1.9% in premarket trade after saying it may exceed full year 2020 guidance.

The world's largest catering firm Compass however expects annual organic revenue to
fall by 19% and said it would impair about 100 million pounds worth of assets as it reviews its
contracts to deal with the blow from the COVID-19 pandemic.

Eyes also on exchange stocks such as Deutsche Boerse, Euronext and LSE
after news that Trump's antitrust chief will scrutinize Wall Street data feed pricing
heavily hit shares in US exchange stocks.

On the COVID-19 treatment front there is some good news. A single dose of Johnson &
Johnson's experimental vaccine produced a strong immune response against the novel coronavirus
in an early-to-mid stage clinical trial, while GSK said it was optimistic
the industry will be able to make an immunisation against COVID-19 widely available next year.

(Danilo Masoni)

*****

MORNING CALL: GOING DOWN POST TRUMP-BIDEN DEBATE (0534 GMT)

Shares in Europe look set for a lower start this morning as a chaotic Trump-Biden debate,
which did little to soothe worries about a contested election, outweighs positive data from
China, where factory activity expanded at a faster pace in September.

Euro STOXX futures were last trading down 0.6%, adding to losses seen yesterday
when markets pulled back after a big rally at the start of the week.

Over in Asia, shares rose slightly with MSCI's broadest index of Asia-Pacific shares outside
Japan up 0.2%, while U.S. futures were last showing declines of 0.7%.

(Danilo Masoni)

*****

More News
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.